EJC paediatric oncology

Keyphrases

Publications

volume 4, 2024

Jean Hunleth, Sarah Burack, Lindsey Kaufman, Caroline Mohrmann, Thembekile Shato, Eric Wiedenman, Janet Njelesani
Inequities in childhood cancer research: A scoping review. EJC paediatric oncology 4 (2024)
Jean Hunleth, Sarah Burack, Lindsey Kaufman, Caroline Mohrmann, Thembekile Shato, Eric Wiedenman, Janet Njelesani
Inequities in childhood cancer research: A scoping review. EJC paediatric oncology 4 (2024)
Jean Hunleth, Sarah Burack, Lindsey Kaufman, Caroline Mohrmann, Thembekile Shato, Eric Wiedenman, Janet Njelesani
Inequities in childhood cancer research: A scoping review. EJC paediatric oncology 4 (2024)

volume 3, 2024

Helen T Orimoloye, Nicholas Nguyen, Chuanjie Deng, Chai Saechao, Beate Ritz, Jorn Olsen, Johnni Hansen, Julia E Heck
Maternal autoimmune disease and its association with childhood cancer: A population-based case-control study in Denmark. EJC paediatric oncology 3 (2024)
Helen T Orimoloye, Nicholas Nguyen, Chuanjie Deng, Chai Saechao, Beate Ritz, Jorn Olsen, Johnni Hansen, Julia E Heck
Maternal autoimmune disease and its association with childhood cancer: A population-based case-control study in Denmark. EJC paediatric oncology 3 (2024)
Helen T Orimoloye, Nicholas Nguyen, Chuanjie Deng, Chai Saechao, Beate Ritz, Jorn Olsen, Johnni Hansen, Julia E Heck
Maternal autoimmune disease and its association with childhood cancer: A population-based case-control study in Denmark. EJC paediatric oncology 3 (2024)
Rebecca Epperly, Stephen Gottschalk, Christopher DeRenzo
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives. EJC paediatric oncology 3 (2024)
Rebecca Epperly, Stephen Gottschalk, Christopher DeRenzo
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives. EJC paediatric oncology 3 (2024)
Rebecca Epperly, Stephen Gottschalk, Christopher DeRenzo
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives. EJC paediatric oncology 3 (2024)
Kevin Louault, Yves A De Clerck, Isabelle Janoueix-Lerosey
The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies. EJC paediatric oncology 3 (2024)
Kevin Louault, Yves A De Clerck, Isabelle Janoueix-Lerosey
The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies. EJC paediatric oncology 3 (2024)
Kevin Louault, Yves A De Clerck, Isabelle Janoueix-Lerosey
The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies. EJC paediatric oncology 3 (2024)

volume 2, 2023

Kris Ann P Schultz, Murali Chintagumpala, Jin Piao, Kenneth S Chen, Rachana Shah, Robyn D Gartrell, Emily Christison-Lagay, Farzana Pashnakar, Jesse L Berry, Allison F O'Neill, Lauren M Vasta, Ashley Flynn, Sarah G Mitchell, Brittani Kn Seynnaeve, Jeremy Rosenblum, Samara L Potter, Junne Kamihara, Carlos Rodriguez-Galindo, Douglas S Hawkins, Theodore W Laetsch
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. EJC paediatric oncology 2 (2023)
Qi Yan, Di He, Douglas I Walker, Karan Uppal, Xuexia Wang, Helen T Orimoloye, Dean P Jones, Beate R Ritz, Julia E Heck
The neonatal blood spot metabolome in retinoblastoma. EJC paediatric oncology 2 (2023)
Qi Yan, Di He, Douglas I Walker, Karan Uppal, Xuexia Wang, Helen T Orimoloye, Dean P Jones, Beate R Ritz, Julia E Heck
The neonatal blood spot metabolome in retinoblastoma. EJC paediatric oncology 2 (2023)
Qi Yan, Di He, Douglas I Walker, Karan Uppal, Xuexia Wang, Helen T Orimoloye, Dean P Jones, Beate R Ritz, Julia E Heck
The neonatal blood spot metabolome in retinoblastoma. EJC paediatric oncology 2 (2023)
Mohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, Sang Mee Lee, Yan Che, Arlene Naranjo, Julie R Park, Samuel L Volchenboum, Tara O Henderson, Susan L Cohn, Ami V Desai
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades. EJC paediatric oncology 2 (2023)
Mohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, Sang Mee Lee, Yan Che, Arlene Naranjo, Julie R Park, Samuel L Volchenboum, Tara O Henderson, Susan L Cohn, Ami V Desai
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades. EJC paediatric oncology 2 (2023)
Eddy Carolina Pedraza, Peter Francis Raguindin, Manya Jerina Hendriks, Anna Katharina Vokinger, Eva De Clercq, Katja Rüesch, Lars Hjorth, André Oscar von Bueren, Eva Maria Tinner, Eva Bergstraesser, Lori Wiener, Gisela Michel
Palliative care services in paediatric oncology centres across Europe: A cross-sectional survey. EJC paediatric oncology 2 (2023)
Eddy Carolina Pedraza, Peter Francis Raguindin, Manya Jerina Hendriks, Anna Katharina Vokinger, Eva De Clercq, Katja Rüesch, Lars Hjorth, André Oscar von Bueren, Eva Maria Tinner, Eva Bergstraesser, Lori Wiener, Gisela Michel
Palliative care services in paediatric oncology centres across Europe: A cross-sectional survey. EJC paediatric oncology 2 (2023)
Qi Yan, Di He, Douglas I Walker, Karan Uppal, Xuexia Wang, Helen T Orimoloye, Dean P Jones, Beate R Ritz, Julia E Heck
The neonatal blood spot metabolome in retinoblastoma. EJC paediatric oncology 2 (2023)
Qi Yan, Di He, Douglas I Walker, Karan Uppal, Xuexia Wang, Helen T Orimoloye, Dean P Jones, Beate R Ritz, Julia E Heck
The neonatal blood spot metabolome in retinoblastoma. EJC paediatric oncology 2 (2023)
Mohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, Sang Mee Lee, Yan Che, Arlene Naranjo, Julie R Park, Samuel L Volchenboum, Tara O Henderson, Susan L Cohn, Ami V Desai
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades. EJC paediatric oncology 2 (2023)

volume 1, 2022

Nancy Broos, Leiah J Brigitha, Annemieke Schuurhof, Heike Röckmann-Helmbach, Wim J E Tissing, Rob Pieters, Inge M van der Sluis, Marike B Stadermann
Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy. EJC paediatric oncology 1 (2022)